These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 11351317)

  • 1. Increased incidence of small and well-differentiated breast tumours in post-menopausal women following hormone-replacement therapy.
    Manjer J; Malina J; Berglund G; Bondeson L; Garne JP; Janzon L
    Int J Cancer; 2001 Jun; 92(6):919-22. PubMed ID: 11351317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hormone replacement therapy in relation to breast carcinoma incidence rate ratios: a prospective Danish cohort study.
    Tjønneland A; Christensen J; Thomsen BL; Olsen A; Overvad K; Ewertz M; Mellemkjaer L
    Cancer; 2004 Jun; 100(11):2328-37. PubMed ID: 15160335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast cancer with different prognostic characteristics developing in Danish women using hormone replacement therapy.
    Stahlberg C; Pedersen AT; Andersen ZJ; Keiding N; Hundrup YA; Obel EB; Møller S; Rank F; Ottesen B; Lynge E
    Br J Cancer; 2004 Aug; 91(4):644-50. PubMed ID: 15238982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast tumours following combined hormone replacement therapy express favourable prognostic factors.
    Borgquist S; Anagnostaki L; Jirström K; Landberg G; Manjer J
    Int J Cancer; 2007 May; 120(10):2202-7. PubMed ID: 17278089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hormone replacement therapy and risk of breast cancer with a favorable histology: results of the Iowa Women's Health Study.
    Gapstur SM; Morrow M; Sellers TA
    JAMA; 1999 Jun; 281(22):2091-7. PubMed ID: 10367819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Risk of Breast Cancer in Women Using Menopausal Hormone Replacement Therapy in Taiwan.
    Liu JY; Chen TJ; Hwang SJ
    Int J Environ Res Public Health; 2016 May; 13(5):. PubMed ID: 27187426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased risk of breast cancer following different regimens of hormone replacement therapy frequently used in Europe.
    Stahlberg C; Pedersen AT; Lynge E; Andersen ZJ; Keiding N; Hundrup YA; Obel EB; Ottesen B
    Int J Cancer; 2004 May; 109(5):721-7. PubMed ID: 14999781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and biological characteristics of breast cancers in post-menopausal women receiving hormone replacement therapy for menopause.
    Salmon RJ; Ansquer Y; Asselain B; Languille O; Lesec G; Remvikos Y
    Oncol Rep; 1999; 6(3):699-703. PubMed ID: 10203618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Duration of hormone replacement therapy, breast tumour size and grade in a screening programme.
    Gertig DM; Erbas B; Fletcher A; Amos A; Kavanagh AM
    Breast Cancer Res Treat; 2003 Aug; 80(3):267-73. PubMed ID: 14503799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormone replacement therapy containing progestins and given continuously increases breast carcinoma risk in Sweden.
    Olsson HL; Ingvar C; Bladström A
    Cancer; 2003 Mar; 97(6):1387-92. PubMed ID: 12627501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast Tumor Prognostic Characteristics and Biennial vs Annual Mammography, Age, and Menopausal Status.
    Miglioretti DL; Zhu W; Kerlikowske K; Sprague BL; Onega T; Buist DS; Henderson LM; Smith RA;
    JAMA Oncol; 2015 Nov; 1(8):1069-77. PubMed ID: 26501844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns of alcohol consumption and breast cancer risk in the California Teachers Study cohort.
    Horn-Ross PL; Canchola AJ; West DW; Stewart SL; Bernstein L; Deapen D; Pinder R; Ross RK; Anton-Culver H; Peel D; Ziogas A; Reynolds P; Wright W
    Cancer Epidemiol Biomarkers Prev; 2004 Mar; 13(3):405-11. PubMed ID: 15006916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hormone replacement therapy and breast cancer in former users of oral contraceptives--The Norwegian Women and Cancer study.
    Lund E; Bakken K; Dumeaux V; Andersen V; Kumle M
    Int J Cancer; 2007 Aug; 121(3):645-8. PubMed ID: 17372914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective study of different types of hormone replacement therapy use and the risk of subsequent breast cancer: the women's health in the Lund area (WHILA) study (Sweden).
    Jernström H; Bendahl PO; Lidfeldt J; Nerbrand C; Agardh CD; Samsioe G
    Cancer Causes Control; 2003 Sep; 14(7):673-80. PubMed ID: 14575365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hormone replacement therapy regimens and breast cancer risk(1).
    Weiss LK; Burkman RT; Cushing-Haugen KL; Voigt LF; Simon MS; Daling JR; Norman SA; Bernstein L; Ursin G; Marchbanks PA; Strom BL; Berlin JA; Weber AL; Doody DR; Wingo PA; McDonald JA; Malone KE; Folger SG; Spirtas R
    Obstet Gynecol; 2002 Dec; 100(6):1148-58. PubMed ID: 12468157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hormone use for menopausal symptoms and risk of breast cancer. A Danish cohort study.
    Ewertz M; Mellemkjaer L; Poulsen AH; Friis S; Sørensen HT; Pedersen L; McLaughlin JK; Olsen JH
    Br J Cancer; 2005 Apr; 92(7):1293-7. PubMed ID: 15785751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Weight gain, body mass index, hormone replacement therapy, and postmenopausal breast cancer in a large prospective study.
    Feigelson HS; Jonas CR; Teras LR; Thun MJ; Calle EE
    Cancer Epidemiol Biomarkers Prev; 2004 Feb; 13(2):220-4. PubMed ID: 14973094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast cancer risk in relation to different types of hormone replacement therapy in the E3N-EPIC cohort.
    Fournier A; Berrino F; Riboli E; Avenel V; Clavel-Chapelon F
    Int J Cancer; 2005 Apr; 114(3):448-54. PubMed ID: 15551359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hormone replacement therapy after a diagnosis of breast cancer in relation to recurrence and mortality.
    O'Meara ES; Rossing MA; Daling JR; Elmore JG; Barlow WE; Weiss NS
    J Natl Cancer Inst; 2001 May; 93(10):754-62. PubMed ID: 11353785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer.
    Lancet; 1997 Oct; 350(9084):1047-59. PubMed ID: 10213546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.